Company Update: Agilent Technologies Inc (NYSE:A) – Dako, an Agilent Technologies Company, Announces Availability of New Lung Cancer Test in Europe

[Business Wire] – Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, today announced the commercial availability in the EU of a new test that can identify PD-L1 expression levels on the surface of non-small cell lung cancer tumor cells and provide information on the survival benefit with OPDIVO® for patients with non-squamous NSCLC. Read more on this. Agilent Technologies, Inc. (A) , currently valued at $13.19B, opened this morning at $39.29. Looking at today’s market, A one day range is $39.17 to $40.25 and has traded between $33.12 and $43.59 over the past 12 months. A shares are currently priced at 21.11x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s 6.09x earnings multiple for the same period. And for dividend hunters, the company pays shareholders $0.46 per share annually in dividends, yielding 1.15%. In a review of the consensus earnings estimate this quarter, 14 sell-side analysts are looking at $0.39 per share, which would be $0.01 better than the year-ago quarter and a $0.04 sequential decrease. In looking at the bigger picture, the full-year EPS estimate of $1.86 would be a $0.12 improvement when compared to the previous year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $979.62 Million. If reported, that would be a 1.73% increase over the year-ago quarter. More recently, Deutsche Bank Initiated A at Hold (Jan 7, 2016). Previously, UBS Initiated A at to Neutral. Investors should keep in mind is that the average price target is $44.93, which is 14.35% above where the stock opened this morning. See more in (NYSE:A) Similar Articles: Company Update: Agilent Technologies Inc (NYSE:A) – Agilent Technologies Publishes Overview of Best Practices for Breast Cancer Diagnosis Company Update: Agilent Technologies Inc (NYSE:A) – Agilent Technologies Reports First-Quarter 2016 Results Market Update: Agilent Technologies Inc (NYSE:A) – Dako, an Agilent Technologies Company, Announces Expanded FDA Approval of Complementary Diagnostic Test to Include Melanoma